Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-20-053873

Options or other derivatives

  • Director acquired 450,846 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Haddadin Yezan Munther · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-10-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +290,372 290,372 D
2020-10-05 Grant or award : show line 2 in the form Stock Option (Right to Buy) +160,474 $0.51 $82,500 160,474 D
Loading xslF345X03/doc4.xml…